Live on the platform & Ready for investment!
- On December 22, 2017
- By GrowthInvest Admin
eXroid was founded in 2013 to bring the Ultroid US electrotherapy treatment for haemorrhoids from the US to Europe. Haemorrhoids (piles) are an ailment that affects an estimated 8 million people in the UK and an estimated 80 million Europeans. There is a vast unmet need, as only some 66,000 people in the UK get treatment each year. Offering a virtually painless electrotherapy treatment with no recovery time, eXroid is seeking to exploit this unmet need.
If you would be interested in further information regarding this investment, view our investment proposal here.
GET IN TOUCH!
CALL US020 7071 3945
FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.